ArticleHepatology (Baltimore, Md.)2026

Consistent efficacy of efruxifermin across PNPLA3 genotypes in phase 2b trials in MASH.

Naga Chalasani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.